Search Results - "Moors, Ellen"

Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factors by Strohm, Lea, Hehakaya, Charisma, Ranschaert, Erik R., Boon, Wouter P. C., Moors, Ellen H. M.

“…Objective The objective was to identify barriers and facilitators to the implementation of artificial intelligence (AI) applications in clinical radiology in…”
Get full text

Reducing post-harvest food losses through innovative collaboration: Insights from the Colombian and Mexican avocado supply chains by Arias Bustos, Carolina, Moors, Ellen H.M.

“…Postharvest losses along food supply chains have far reaching consequences for the environment and affect the social and economic conditions of food supply…”
Get full text

Institutional power play in innovation systems: The case of Herceptin by Kukk, Piret, Moors, Ellen H.M., Hekkert, Marko P.

“…•We combine TIS framework with insights from institutional change literature.•We show how institutional change depends on other system building activities.•We…”
Get full text

To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies? by de Haan, Freek, Bolarinwa, Oladimeji Akeem, Guissou, Rosemonde, Tou, Fatoumata, Tindana, Paulina, Boon, Wouter P C, Moors, Ellen H M, Cheah, Phaik Yeong, Dhorda, Mehul, Dondorp, Arjen M, Ouedraogo, Jean Bosco, Mokuolu, Olugbenga A, Amaratunga, Chanaki

“…Triple artemisinin-based combination therapies (TACTs) are being developed as a response to artemisinin and partner drug resistance in the treatment of…”
Get full text

Gimme shelter? Heterogeneous preferences for tangible and intangible resources when choosing an incubator by van Weele, Marijn A., van Rijnsoever, Frank J., Groen, Menno, Moors, Ellen H. M.

“…The rapidly growing and diversifying incubator population has led to increasing efforts to understand why entrepreneurs prefer one incubator over another…”
Get full text

A standardised framework to identify optimal animal models for efficacy assessment in drug development by Ferreira, Guilherme S, Veening-Griffioen, Désirée H, Boon, Wouter P C, Moors, Ellen H M, Gispen-de Wied, Christine C, Schellekens, Huub, van Meer, Peter J K

“…Poor translation of efficacy data derived from animal models can lead to clinical trials unlikely to benefit patients-or even put them at risk-and is a…”
Get full text

Valuing health technology – habilitating and prosthetic strategies in personal health systems by Peine, Alexander, Moors, Ellen H.M.

“…This paper explores the tensions in ICT-driven personal health systems innovation and the impact of these tensions on valuing health innovation for older…”
Get full text

Exploring dynamics and strategies of niche protection by Boon, Wouter P.C., Moors, Ellen H.M., Meijer, Albert J.

“…•We study dynamics of protection in different phases of niche development.•Niche protection is explored in HIV and pandemic influenza cases.•Interactions…”
Get full text

Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam by Cao, Van Anh Thi, Nguyen, Thieu Quang, Le Quyen, Duong, Boon, Wouter P. C, Moors, Ellen H. M, Dondorp, Arjen M, de Haan, Freek, Amaratunga, Chanaki

“…Background This study investigates the processes regarding changing malaria treatment policies in Vietnam. Moreover, it explores the feasibility of introducing…”
Get full text

Toward Responsible Artificial Intelligence in Long-Term Care: A Scoping Review on Practical Approaches by Lukkien, Dirk R M, Nap, Henk Herman, Buimer, Hendrik P, Peine, Alexander, Boon, Wouter P C, Ket, Johannes C F, Minkman, Mirella M N, Moors, Ellen H M

“…Artificial intelligence (AI) is widely positioned to become a key element of intelligent technologies used in the long-term care (LTC) for older adults. The…”
Get full text

Caring for healthcare entrepreneurs — Towards successful entrepreneurial strategies for sustainable innovations in Dutch healthcare by Janssen, Maarten, Moors, Ellen H.M.

“…The sustainability of current healthcare systems is threatened by several societal developments, including an aging population, an increase of unmet medical…”
Get full text

From Mattering to Mattering More: ‘Goods’ and ‘Bads’ in Ageing and Innovation Policy Discourses by Greubel, Carla, Moors, Ellen H. M., Peine, Alexander

“…This paper provides an empirical ethics analysis of the goods and bads enacted in EU ageing and innovation policy discourses. It revolves around a case study…”
Get full text

The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso by Guissou, Rosemonde M, Amaratunga, Chanaki, de Haan, Freek, Tou, Fatoumata, Cheah, Phaik Yeong, Yerbanga, R Serge, Moors, Ellen H M, Dhorda, Mehul, Tindana, Paulina, Boon, Wouter P C, Dondorp, Arjen M, Ouédraogo, Jean Bosco

“…Widespread artemisinin resistance in Africa could be catastrophic when drawing parallels with the failure of chloroquine in the 1970s and 1980s. This article…”
Get full text

Demand articulation in emerging technologies: Intermediary user organisations as co-producers? by Boon, Wouter P.C., Moors, Ellen H.M., Kuhlmann, Stefan, Smits, Ruud E.H.M.

“…User involvement is assumed to be beneficial to innovation processes. Intermediary user organisations contribute to articulating societal demands for…”
Get full text

Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion by de Haan, Freek, Amaratunga, Chanaki, Thi, Van Anh Cao, Orng, Long Heng, Vonglokham, Manithong, Quang, Thieu Nguyen, Lek, Dysoley, Boon, Wouter P. C, Dondorp, Arjen M, Moors, Ellen H. M

“…Background This is a qualitative study to identify implementation challenges for deploying triple artemisinin-based combination therapy (TACT) in the Greater…”
Get full text

Towards a sustainable system of drug development by Moors, Ellen H.M., Cohen, Adam F., Schellekens, Huub

“…•Study of impeding factors leading to system failure in drug development.•Overview of solution directions to repair current drug development system.•Importance…”
Get full text

Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease by Veening-Griffioen, Désirée H., Ferreira, Guilherme S., van Meer, Peter J.K., Boon, Wouter P.C., Gispen-de Wied, Christine C., Moors, Ellen H.M., Schellekens, Huub

“…Clinical trial failures (>99%) in Alzheimer's disease are in stark contrast to positive efficacy data in animals. We evaluated the correlation between animal…”
Get full text

Institutionalisation of convergent medical innovation: an empirical study of the MRI-guided linear accelerator in the Netherlands and the United States by Hehakaya, Charisma, Moors, Ellen H. M.

“…Although convergence is a major trend in the development of medical innovations, the implications of the institutionalisation of convergent innovation are…”
Get full text

Mental models of the protein shift: Exploring consumers’ perceptions of the transition by van den Boom, Lieke A.T.P., van den Broek, Karlijn L., Kroese, Floor M., Moors, Ellen H.M., de Ridder, Denise T.D.

“…The protein transition is one of today's major societal challenges to mitigate climate change. To support lasting consumer engagement, it has been suggested to…”
Get full text

How do people understand the spread of COVID-19 infections? Mapping mental models of factors contributing to the pandemic by de Ridder, Denise T. D., van den Boom, Lieke A. T. P., Kroese, Floor M., Moors, Ellen H. M., van den Broek, Karlijn L.

“…To describe the mental models people hold about the COVID-19 pandemic, with a focus on how they understand the factors that drive the spread of COVID-19 and…”
Get full text